Core Insights - Gelteq Limited will present at the Q4 Investor Summit Virtual on December 9, 2025, focusing on its growth strategy, market positioning, and upcoming catalysts [1] - The Investor Summit aims to connect investors with disruptive small and microcap companies, highlighting those with compelling value propositions and near-term growth drivers [1] Company Overview - Gelteq Limited, headquartered in Melbourne, Australia, specializes in developing and commercializing gel-based oral delivery solutions for various applications, including prescription drugs, nutraceuticals, pet care, and sports nutrition [3] - The company's proprietary formulation technology addresses challenges in conventional drug delivery, such as taste masking, swallowing difficulties, and precision dosing [3] Event Details - Nathan Givoni, CEO of Gelteq, will present at 4:00 PM ET on December 9, 2025, and will also host one-on-one meetings with Institutional and High Net Worth investors on December 10 [2][6] - Interested parties can request a one-on-one meeting through Gelteq's investor relations [2]
Gelteq to Present at Investor Summit Virtual on December 9, 2025